CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor.
about
CDK12 regulates alternative last exon mRNA splicing and promotes breast cancer cell invasion.Chimeric RNAs and their implications in cancer.Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability.Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype.
P2860
CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
CLK-dependent exon recognition ...... ovel small molecule inhibitor.
@en
CLK-dependent exon recognition ...... ovel small molecule inhibitor.
@nl
type
label
CLK-dependent exon recognition ...... ovel small molecule inhibitor.
@en
CLK-dependent exon recognition ...... ovel small molecule inhibitor.
@nl
prefLabel
CLK-dependent exon recognition ...... ovel small molecule inhibitor.
@en
CLK-dependent exon recognition ...... ovel small molecule inhibitor.
@nl
P2093
P2860
P1476
CLK-dependent exon recognition ...... ovel small molecule inhibitor.
@en
P2093
Adrian Wan
Aiko Murai
Arusha Oloumi
Atsushi Nakanishi
Daisuke Morishita
Esther Kong
Gregg B Morin
Hirokazu Tozaki
Hiroyoshi Toyoshiba
Jamie Rosner
P2860
P2888
P356
10.1038/S41467-016-0008-7
P407
P577
2017-02-23T00:00:00Z
P6179
1083808735